Form 8-K - Current report:
SEC Accession No. 0001185185-25-000078
Filing Date
2025-02-05
Accepted
2025-02-04 21:21:40
Documents
14
Period of Report
2025-01-31
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tcrg20250204_8k.htm   iXBRL 8-K 22512
2 EXHIBIT 99.1 ex_775001.htm EX-99.1 10886
  Complete submission text file 0001185185-25-000078.txt   167673

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA tcrg-20250131.xsd EX-101.SCH 3042
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE tcrg-20250131_lab.xml EX-101.LAB 21775
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tcrg-20250131_pre.xml EX-101.PRE 11822
17 EXTRACTED XBRL INSTANCE DOCUMENT tcrg20250204_8k_htm.xml XML 2925
Mailing Address 650 PONCE DE LEON AVE SUITE 300 #2334 ATLANTA GA 30308
Business Address 650 PONCE DE LEON AVE SUITE 300 #2334 ATLANTA GA 30308 404-254-2100
Cannaisseur Group Inc. (Filer) CIK: 0001879270 (see all company filings)

EIN.: 861907561 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-56664 | Film No.: 25590501
SIC: 2833 Medicinal Chemicals & Botanical Products
(CF Office: 03 Life Sciences)